<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR39">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cornelio</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Tamayo</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Flores</surname>
    <given-names>ML</given-names>
   </name>
   <name>
    <surname>Bautista</surname>
    <given-names>JB</given-names>
   </name>
   <name>
    <surname>Tioleco</surname>
    <given-names>PS</given-names>
   </name>
   <name>
    <surname>Gargano</surname>
    <given-names>MA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A phase Ib/II study evaluating the safety, pharmacokinetics, and efficacy of BTH1677 in combination with cetuximab with and without irinotecan in patients with advanced metastatic colorectal cancer</article-title>
  <source>Colorectal Cancer</source>
  <year>2016</year>
  <volume>5</volume>
  <fpage>95</fpage>
  <lpage>108</lpage>
  <pub-id pub-id-type="doi">10.2217/crc-2016-0010</pub-id>
 </element-citation>
</ref>
